(TU) Telus - Ratings and Ratios
Exchange: NYSE •
Country: Canada •
Currency: USD •
Type: Common Stock •
ISIN: CA87971M1032
Mobile, Internet, TV, Security, Health
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 7.95% |
| Yield on Cost 5y | 7.53% |
| Yield CAGR 5y | 3.88% |
| Payout Consistency | 96.1% |
| Payout Ratio | 1.7% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 18.0% |
| Value at Risk 5%th | 28.7% |
| Relative Tail Risk | -3.00% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.18 |
| Alpha | 1.87 |
| CAGR/Max DD | -0.25 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.494 |
| Beta | -0.011 |
| Beta Downside | -0.181 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.95% |
| Mean DD | 16.66% |
| Median DD | 17.42% |
Description: TU Telus December 17, 2025
Telus Corp (NYSE:TU) operates two primary divisions: Technology Solutions, which delivers a broad portfolio of telecom infrastructure, mobile and fixed voice/data services, cloud, data analytics, and health-tech offerings; and Digitally-Led Customer Experiences, focused on AI-driven digital transformation, content management, and customer-engagement platforms.
Key operating metrics (2023) include ≈ $15.9 billion in total revenue, a 13.2% EBITDA margin, and roughly 13 million wireless subscribers, with a 5-year CAGR of ~2.5% in post-paid lines. Growth is driven by continued 5G rollout, rising demand for health-technology services (e.g., Telus Health’s virtual care platform now serves over 1 million users), and a regulated Canadian telecom market that limits price competition but ensures stable cash flows. Capital expenditures remain high, with FY2024 capex guidance of $2.2 billion, reflecting network expansion and cloud infrastructure investment.
For a deeper quantitative view, you may find ValueRay’s detailed financial models useful.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 1.18b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 2.31 > 1.0 |
| NWC/Revenue: -8.30% < 20% (prev -13.86%; Δ 5.56% < -1%) |
| CFO/TA 0.10 > 3% & CFO 4.39b > Net Income 1.18b |
| Net Debt (20.16b) to EBITDA (6.75b): 2.99 < 3 |
| Current Ratio: 0.76 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.54b) vs 12m ago 3.84% < -2% |
| Gross Margin: 61.94% > 18% (prev 0.62%; Δ 6132 % > 0.5%) |
| Asset Turnover: 41.20% > 50% (prev 35.03%; Δ 6.17% > 0%) |
| Interest Coverage Ratio: 1.83 > 6 (EBITDA TTM 6.75b / Interest Expense TTM 1.50b) |
Altman Z'' 0.50
| A: -0.04 (Total Current Assets 5.30b - Total Current Liabilities 7.00b) / Total Assets 42.26b |
| B: 0.01 (Retained Earnings 359.0m / Total Assets 42.26b) |
| C: 0.06 (EBIT TTM 2.73b / Avg Total Assets 49.62b) |
| D: 0.34 (Book Value of Equity 10.22b / Total Liabilities 29.68b) |
| Altman-Z'' Score: 0.50 = B |
Beneish M -3.33
| DSRI: 0.73 (Receivables 2.99b/4.02b, Revenue 20.45b/19.96b) |
| GMI: 1.00 (GM 61.94% / 61.99%) |
| AQI: 0.97 (AQ_t 0.58 / AQ_t-1 0.59) |
| SGI: 1.02 (Revenue 20.45b / 19.96b) |
| TATA: -0.08 (NI 1.18b - CFO 4.39b) / TA 42.26b) |
| Beneish M-Score: -3.33 (Cap -4..+1) = AA |
ValueRay F-Score (Strict, 0-100) 58.10
| 1. Piotroski: 4.50pt |
| 2. FCF Yield: 4.44% |
| 3. FCF Margin: 10.66% |
| 4. Debt/Equity: 1.88 |
| 5. Debt/Ebitda: 2.99 |
| 6. ROIC - WACC: 0.35% |
| 7. RoE: 8.15% |
| 8. Revenue Trend: 77.12% |
| 9. EPS Trend: -47.50% |
What is the price of TU shares?
As of January 27, 2026, the stock is trading at USD 13.86 with a total of 2,645,369 shares traded.
Over the past week, the price has changed by +4.13%, over one month by +7.44%, over three months by -5.23% and over the past year by +2.87%.
Over the past week, the price has changed by +4.13%, over one month by +7.44%, over three months by -5.23% and over the past year by +2.87%.
Is TU a buy, sell or hold?
Telus has received a consensus analysts rating of 3.56.
Therefor, it is recommend to hold TU.
- Strong Buy: 3
- Buy: 5
- Hold: 9
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the TU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 16.8 | 21.4% |
| Analysts Target Price | 16.8 | 21.4% |
| ValueRay Target Price | 14.5 | 4.5% |
TU Fundamental Data Overview January 27, 2026
Market Cap CAD = 29.44b (21.51b USD * 1.3685 USD.CAD)
P/E Trailing = 24.3333
P/E Forward = 17.7936
P/S = 1.0521
P/B = 1.8683
P/EG = 1.4443
Revenue TTM = 20.45b CAD
EBIT TTM = 2.73b CAD
EBITDA TTM = 6.75b CAD
Long Term Debt = 25.79b CAD (from longTermDebt, last quarter)
Short Term Debt = 2.96b CAD (from shortTermDebt, last quarter)
Debt = 21.48b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = 20.16b CAD (from netDebt column, last quarter)
Enterprise Value = 49.09b CAD (29.44b + Debt 21.48b - CCE 1.83b)
Interest Coverage Ratio = 1.83 (Ebit TTM 2.73b / Interest Expense TTM 1.50b)
EV/FCF = 22.53x (Enterprise Value 49.09b / FCF TTM 2.18b)
FCF Yield = 4.44% (FCF TTM 2.18b / Enterprise Value 49.09b)
FCF Margin = 10.66% (FCF TTM 2.18b / Revenue TTM 20.45b)
Net Margin = 5.77% (Net Income TTM 1.18b / Revenue TTM 20.45b)
Gross Margin = 61.94% ((Revenue TTM 20.45b - Cost of Revenue TTM 7.78b) / Revenue TTM)
Gross Margin QoQ = 61.67% (prev 63.07%)
Tobins Q-Ratio = 1.16 (Enterprise Value 49.09b / Total Assets 42.26b)
Interest Expense / Debt = 1.86% (Interest Expense 400.0m / Debt 21.48b)
Taxrate = 26.70% (157.0m / 588.0m)
NOPAT = 2.00b (EBIT 2.73b * (1 - 26.70%))
Current Ratio = 0.76 (Total Current Assets 5.30b / Total Current Liabilities 7.00b)
Debt / Equity = 1.88 (Debt 21.48b / totalStockholderEquity, last quarter 11.40b)
Debt / EBITDA = 2.99 (Net Debt 20.16b / EBITDA 6.75b)
Debt / FCF = 9.25 (Net Debt 20.16b / FCF TTM 2.18b)
Total Stockholder Equity = 14.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.38% (Net Income 1.18b / Total Assets 42.26b)
RoE = 8.15% (Net Income TTM 1.18b / Total Stockholder Equity 14.46b)
RoCE = 6.79% (EBIT 2.73b / Capital Employed (Equity 14.46b + L.T.Debt 25.79b))
RoIC = 4.32% (NOPAT 2.00b / Invested Capital 46.29b)
WACC = 3.98% (E(29.44b)/V(50.91b) * Re(5.88%) + D(21.48b)/V(50.91b) * Rd(1.86%) * (1-Tc(0.27)))
Discount Rate = 5.88% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 2.52%
[DCF Debug] Terminal Value 87.97% ; FCFF base≈1.96b ; Y1≈2.29b ; Y5≈3.46b
Fair Price DCF = 52.40 (EV 101.43b - Net Debt 20.16b = Equity 81.27b / Shares 1.55b; r=5.90% [WACC]; 5y FCF grow 18.29% → 2.90% )
EPS Correlation: -47.50 | EPS CAGR: -1.51% | SUE: -1.33 | # QB: 0
Revenue Correlation: 77.12 | Revenue CAGR: 3.46% | SUE: -0.08 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.18 | Chg30d=+0.000 | Revisions Net=+0 | Analysts=5
EPS next Year (2026-12-31): EPS=0.76 | Chg30d=-0.010 | Revisions Net=-4 | Growth EPS=+8.2% | Growth Revenue=+2.5%
P/E Trailing = 24.3333
P/E Forward = 17.7936
P/S = 1.0521
P/B = 1.8683
P/EG = 1.4443
Revenue TTM = 20.45b CAD
EBIT TTM = 2.73b CAD
EBITDA TTM = 6.75b CAD
Long Term Debt = 25.79b CAD (from longTermDebt, last quarter)
Short Term Debt = 2.96b CAD (from shortTermDebt, last quarter)
Debt = 21.48b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = 20.16b CAD (from netDebt column, last quarter)
Enterprise Value = 49.09b CAD (29.44b + Debt 21.48b - CCE 1.83b)
Interest Coverage Ratio = 1.83 (Ebit TTM 2.73b / Interest Expense TTM 1.50b)
EV/FCF = 22.53x (Enterprise Value 49.09b / FCF TTM 2.18b)
FCF Yield = 4.44% (FCF TTM 2.18b / Enterprise Value 49.09b)
FCF Margin = 10.66% (FCF TTM 2.18b / Revenue TTM 20.45b)
Net Margin = 5.77% (Net Income TTM 1.18b / Revenue TTM 20.45b)
Gross Margin = 61.94% ((Revenue TTM 20.45b - Cost of Revenue TTM 7.78b) / Revenue TTM)
Gross Margin QoQ = 61.67% (prev 63.07%)
Tobins Q-Ratio = 1.16 (Enterprise Value 49.09b / Total Assets 42.26b)
Interest Expense / Debt = 1.86% (Interest Expense 400.0m / Debt 21.48b)
Taxrate = 26.70% (157.0m / 588.0m)
NOPAT = 2.00b (EBIT 2.73b * (1 - 26.70%))
Current Ratio = 0.76 (Total Current Assets 5.30b / Total Current Liabilities 7.00b)
Debt / Equity = 1.88 (Debt 21.48b / totalStockholderEquity, last quarter 11.40b)
Debt / EBITDA = 2.99 (Net Debt 20.16b / EBITDA 6.75b)
Debt / FCF = 9.25 (Net Debt 20.16b / FCF TTM 2.18b)
Total Stockholder Equity = 14.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.38% (Net Income 1.18b / Total Assets 42.26b)
RoE = 8.15% (Net Income TTM 1.18b / Total Stockholder Equity 14.46b)
RoCE = 6.79% (EBIT 2.73b / Capital Employed (Equity 14.46b + L.T.Debt 25.79b))
RoIC = 4.32% (NOPAT 2.00b / Invested Capital 46.29b)
WACC = 3.98% (E(29.44b)/V(50.91b) * Re(5.88%) + D(21.48b)/V(50.91b) * Rd(1.86%) * (1-Tc(0.27)))
Discount Rate = 5.88% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 2.52%
[DCF Debug] Terminal Value 87.97% ; FCFF base≈1.96b ; Y1≈2.29b ; Y5≈3.46b
Fair Price DCF = 52.40 (EV 101.43b - Net Debt 20.16b = Equity 81.27b / Shares 1.55b; r=5.90% [WACC]; 5y FCF grow 18.29% → 2.90% )
EPS Correlation: -47.50 | EPS CAGR: -1.51% | SUE: -1.33 | # QB: 0
Revenue Correlation: 77.12 | Revenue CAGR: 3.46% | SUE: -0.08 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.18 | Chg30d=+0.000 | Revisions Net=+0 | Analysts=5
EPS next Year (2026-12-31): EPS=0.76 | Chg30d=-0.010 | Revisions Net=-4 | Growth EPS=+8.2% | Growth Revenue=+2.5%
Additional Sources for TU Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle